Insider: Warmuth Markus President & CEO - Monte Rosa Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 613,471 | 0 | 613,471 |
| Value | $10,542,499.14 | $0.00 | $10,542,499.14 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/02/2026 | DDS | 5,466 | Direct | COM | $17.92 | $97,974.22 | 613,471 |
| 01/07/2026 | DDS | 3,707 | Direct | COM | $23.24 | $86,158.84 | 620,696 |
| 01/07/2026 | DDS | 1,450 | Direct | COM | $23.88 | $34,620.49 | 619,246 |
| 01/07/2026 | DDS | 309 | Direct | COM | $24.57 | $7,593.24 | 618,937 |
| 01/05/2026 | DDS | 10,135 | Direct | COM | $15.17 | $153,747.95 | 624,403 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research